ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Intelgenx Technologies Corp

Intelgenx Technologies Corp (IGX)

0.23
-0.015
(-6.12%)
Closed April 14 4:12PM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
0.23
Bid
0.23
Ask
0.245
Volume
8,463
0.23 Day's Range 0.245
0.135 52 Week Range 0.35
Market Cap
Previous Close
0.245
Open
0.24
Last Trade
500
@
0.23
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
15,132
Shares Outstanding
174,654,000
Dividend Yield
-
PE Ratio
-4.05
Earnings Per Share (EPS)
-0.06
Revenue
1.04M
Net Profit
-9.93M

About Intelgenx Technologies Corp

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Quebec City, Quebec, Can
Founded
1970
Intelgenx Technologies Corp is listed in the Pharmaceutical Preparations sector of the Toronto Stock Exchange with ticker IGX. The last closing price for Intelgenx Technologies was $0.25. Over the last year, Intelgenx Technologies shares have traded in a share price range of $ 0.135 to $ 0.35.

Intelgenx Technologies currently has 174,654,000 shares outstanding. The market capitalization of Intelgenx Technologies is $40.17 million. Intelgenx Technologies has a price to earnings ratio (PE ratio) of -4.05.

IGX Latest News

IntelGenx Announces First Parkinson’s Disease Patients Dosed with Montelukast VersaFilm® in Phase 2 ‘MONTPARK’ Clinical Trial

SAINT LAURENT, Quebec, April 08, 2024 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx") today announced that Montelukast VersaFilm® has been administered...

IntelGenx Updates Status of Buprenorphine Buccal Film ANDA

SAINT LAURENT, Quebec, April 05, 2024 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the “Company” or “IntelGenx”) today announced that its co-developer, Chemo Research SL, through...

IntelGenx Reports Fourth Quarter and Full-Year 2023 Financial Results

SAINT LAURENT, Quebec, March 21, 2024 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx") today reported financial results for the three- and...

IntelGenx to Report Fourth Quarter and Full Year 2023 Financial Results on March 21, 2024 – Conference Call to Follow

SAINT LAURENT, Quebec, March 14, 2024 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical films, today announced that it will...

IntelGenx Enters Into a Third Amended and Restated Loan Agreement With atai Life Sciences

SAINT LAURENT, Quebec, March 11, 2024 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (the “Company”) announces that its wholly-owned subsidiary, IntelGenx Corp...

UPDATE -- IntelGenx Launches Preferred Share Regulation A Offering

SAINT LAURENT, Quebec, Feb. 20, 2024 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx") today announced the launch of a Regulation A offering of up to...

IntelGenx Launches Preferred Share Regulation A Offering

SAINT LAURENT, Quebec, Feb. 20, 2024 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx") today announced the launch of a Regulation A offering of up to...

Studies Validate Advantages of Administering Drugs to Pets via IntelGenx’s VetaFilm® Platform

SAINT LAURENT, Quebec, Feb. 05, 2024 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx") today announced positive results from a proof-of-concept (“POC”...

IntelGenx Announces New Animal Health Partnership; Enters into Development and License Agreements for VetaFilm®

SAINT LAURENT, Quebec, Dec. 18, 2023 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx") today announced that it has entered into development and license...

IntelGenx Announces Closing of Previously Announced Subsequent Non-Brokered Private Placement With atai Life Sciences for Aggregate Gross Proceeds of US$750,000

SAINT LAURENT, Quebec, Dec. 05, 2023 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx” or the “Company”) announces the closing of the previously announced...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.03-11.53846153850.260.260.23136490.24243362CS
40.0156.976744186050.2150.260.21165940.23998373CS
120.03150.20.260.17151320.22271686CS
260.0421.05263157890.190.260.135163430.20357944CS
520.0156.976744186050.2150.350.135197690.21597145CS
156-0.35-60.34482758620.580.790.135306130.35035386CS
260-0.35-60.34482758620.580.790.135306130.35035386CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PXMDPaxMedica Inc
$ 0.8385
(103.59%)
114.3M
MNDRMobile health Network Solutions
$ 14.87
(45.78%)
10.66M
CNXAConnexa Sports Technologies Inc
$ 1.50
(38.89%)
16.88M
PRZOParaZero Technologies Ltd
$ 1.08
(38.46%)
12.94M
BENFBeneficient
$ 0.09542
(38.09%)
122.81M
MOTSMotus GI Holdings Inc
$ 0.2631
(-37.76%)
1.79M
CISSC3is Inc
$ 1.865
(-35.24%)
5.7M
LXEHLixiang Education Holding Company Ltd
$ 0.4325
(-33.46%)
3.12M
GVHGlobavend Holdings Ltd
$ 1.20
(-29.82%)
227.4k
SLNHSoluna Holdings Inc
$ 1.59
(-28.05%)
423.89k
SQQQProShares UltraPro Short QQQ
$ 10.89
(4.71%)
176.08M
NKLANikola Corporation
$ 0.7014
(-2.18%)
134.38M
BENFBeneficient
$ 0.09542
(38.09%)
122.81M
PXMDPaxMedica Inc
$ 0.8385
(103.59%)
114.3M
AAPLApple Inc
$ 176.55
(0.86%)
101.67M

IGX Discussion

View Posts
RS500 RS500 12 months ago
Hmm Horst is out Gorham is the new CEO @ $400K per year and boat load of shares. Hope he will earn them.
👍️ 1
Lc3ltd Lc3ltd 1 year ago
FDA rejected Eli Lilly's attempt for quick approval of Alzheimer's drug

https://www.usatoday.com/story/news/health/2023/01/20/fda-rejects-eli-lilly-alzheimers-drug-donanemab/11089161002/
👍️0
RS500 RS500 1 year ago
Four more days like today and I will be about even! LOL.

I suspect though that this action will not be sustained, I hope to be proven wrong.
👍️0
railroadman railroadman 2 years ago
Nice post. The market reaction to their new was huge. We wait for the first indications of Montelukest. If positive, anyone guess what SP will do and just as important, what pharma company will come knocking at the door????? Company is quite tight lipped about the current clinical trials. I'm sure fully supported by atai. They floated a private placement to fund the studies of 2.1 Million. Just don't know it that will get them through the trials.
👍️0
Lc3ltd Lc3ltd 2 years ago
Lecanemab, an Alzheimer’s drug from Eisai and Biogen, slowed cognitive decline in patients with early Alzheimer’s by 27% over 18 months in a final-phase trial, the companies said yesterday. That rate of decline met the study’s targets and offers hope to the 6 million people in the US with Alzheimer’s that their dementia can be slowed down or delayed. The companies hope lecanemab will fare better commercially than their previous Alzheimer’s drug Aduhelm—which was a total flop.
👍️0
IGXT_GLEN IGXT_GLEN 2 years ago
20s!
👍️0
plbiinvestor plbiinvestor 3 years ago
Info on Chyll
👍️0
railroadman railroadman 3 years ago
Expectations center around news on Heritage, Rizaport Spain. Update on Tilray status.
Maybe a partner of for Tadalafil. Restart of Montelukest trials with higher dose.

Timing is looking like news in Sept. Waiting for update on Vetrafilm.

JMHO close but no defined timeline.
👍️0
Porman Porman 3 years ago
This is steadily going up ATM and not much attention. Anybody else out there watching this one? Looks like cricket land on the message board.
👍️0
ericherbst ericherbst 3 years ago
Near Term Catalysts:
-TSX Uplisting
-Significantly larger Heritage CBD PO
-Announcement of Tadalafil commercial partner
-Rizaport Spain commercial launch

Make sure you also check out the IGXT Reddit board that was created earlier this month. There is already some very good content there. IGXT has a lot of potential in the short term. If you like what you see, don't forget to join. Just search IGXT Reddit. There is a good poll right now on approval of IGXT's TSX uplisting application. The majority of respondents think that IGXT will get uplisted to the TSX in June.
👍️0
ericherbst ericherbst 3 years ago
IGXT Looking Very Promising after Closing the ATAI Strategic investment. Lots of cash in the bank and management should now be able to focus on execution and generating revenue.
👍️0
conix conix 3 years ago
IGXT chart

👍️0
bobst2003 bobst2003 3 years ago
Whew, almost bought the other day. Saved some money by not buying
👍️0
plbiinvestor plbiinvestor 3 years ago
I emailed Andre about a question I had and after he answered it, he asked this:

Can you remind everyone on the message board that we need everyone to vote on both resolution 4 and 5 for the deal to go through.. its nice to be excited about Atai but the vote is crucial, we need 56 million shares to vote for resolution 5.

Please vote if you haven't already. Please spread the word to vote.

Thank you
👍️0
RS500 RS500 3 years ago
This seems to have been understated "This first-ever shipment from our Montreal facility of commercial quantities"
This is a clear indication that the factory lab, has the ability to produce now and there should be no further inspection or certification hurdles to cross.
👍️0
Lc3ltd Lc3ltd 3 years ago
IntelGenx Ships First CBD Filmstrip Order to Heritage Cannabis
SAINT LAURENT, Quebec, March 31, 2021 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX)(OTCQB:IGXT) ("Company" or "IntelGenx") today announced that, further to its press releases of January 7 and March 25, 2021, it has completed its first shipment, consisting of 75,000 CBD Filmstrips, to Heritage Cannabis Holdings Corp. (“Heritage Cannabis”) (CSE:CANN).

The CBD Filmstrips were produced at IntelGenx’s manufacturing facility under Canadian GPP conditions and registered as a product for sale with Health Canada as a cannabis product governed by the Cannabis Act and with the Australian Department of Health’s Therapeutic Goods Administration as a medicinal cannabis product governed by the Narcotic Drugs Act.

Dr. Horst G. Zerbe, CEO of IntelGenx, commented, “This first-ever shipment from our Montreal facility of commercial quantities of an oral thin film product based on our VersaFilm® technology marks the achievement of another important milestone for our Company. We are looking forward to continuing to build a strong partnership with Heritage Cannabis, which shares our commitment to making innovative and high-quality oral thin film products available to medical cannabis consumers.”

“We are excited to introduce this innovative, rapid acting sublingual filmstrip CBD product that is based on proven pharmaceutical drug delivery technology into the Canadian and Australian markets,” commented Umar Syed, President of Medical Division at Heritage Cannabis. “We believe the future of the oral cannabinoid market will be dominated by products based on innovative technologies such as VersaFilm® that can deliver superior absorption and product performance.”

👍️0
IGXT_GLEN IGXT_GLEN 3 years ago
https://www.google.com/amp/s/www.cantechletter.com/2021/03/intelgenx-is-a-double-from-here-says-leede-jones-gable/amp/
👍️0
 mc67 mc67 3 years ago
$IGXT DD (opinion) by Tim on Ya-00: Our Partner Heritage Cannabis: Heritage achieves Strong Sales Growth, Reaches First Million Dollar Revenues Week.

Heritage Cannabis Announces Closing of Public Offering for Gross Proceeds of $13,846,000.

Heritage Cannabis Announces Receipt of the First Health Canada Cannabis Export License Granted for Brazil. IntelGenx is currently manufacturing CBD oral film strips for Heritage Cannabis that is scheduled to be delivered in Q221.

Heritage will no doubt be debuting our films in Canada, USA, Australia and now Brazil real soon.

Heritage has been building-out several successful brands with a diversified line of attractively packaged and obviously well-selling CBD cannabis products.

Also: Don't forget that Tilray Owns 100% Exclusive World Wide Rights to IntelGenx' Immediate Release Precision Dosed THC Oral Film Strips (USPTO Patent Pending).

Keep in mind, I posted last week Aleafia's recent press release stating that their first month of 2021 saw dramatically increased sales with revenues surpassing all of their previous 4th quarters numbers PRIMARELY driven by strong sales of their Kin Slips THC Oral Film Strips.

All cylinders will be firing real soon in my opinion. IGXT up +166% in the last 6 months tells me more than just Peter Theil has been paying attention to us.

Things I would like to see on Monday or Tuesday morning:

1. IntelGenx Announces First THC Oral Film Strip Order from Tilray

or,

2. IntelGenx Announces First Rizaport Migraine Oral Film Strip Order from Excelsis

or,

3. IntelGenx Announces VetaFilm Partnership with Merck Animal Health, Novartis Animal Health, etc, etc.

As we all witnessed with last weeks dramatic news of ATAI's proposed equity stake, the news cycle is "heating-up". One only needs to refer to the 3 month and 6 month charts for illustration of that fact.

Great luck to all next week!!
👍️0
 mc67 mc67 3 years ago
More and more Marijuana legalization will wake these Sleeping beauties up IMO ;)
👍️0
IGXT_GLEN IGXT_GLEN 3 years ago
Hey man... Kudos to you for shareholders, but unfortunately no one is here to listen... I’ve been in IGXT for years along with some VERY loyal “bag holders”... We all understand the significance of IGXT but can’t comprehend the $P! It’s becoming exhausting carrying this mantle...
👍️0
 mc67 mc67 3 years ago
$IGXT DD (opinion) by Tim on Ya-00
The company reported 3Q20 revenues of $510,000 an increase of +736% yoy results. Licensing and R&D generating impressive revenue increases. Next week IGXT will report similar yoy quarterly results of well over +800% increase in revenues. Next week Horst and Andre will delivery the very best and most positive company report in the company's history. Peter Theil's ATAI wants to take a US$12M equity stage in IGXT purchasing 59 million shares at .35 cents each representing a 25% stake in the company. When/if ATAI exercises all their warrants they will control 35% of the company and have directors placed on the board.
This ship has been most excellently "righted" and we are now about to embark on a life changing journey.

Share structure will look something like this after ATAI's purchase:

IGXT
171M total shares outstanding
78M shares held by insiders (47% insider ownership)
96M shares in the float

Major holders:
ATAI 59M shares
Horst and Ingrid Zerbe 10.3M shares

Will ATAI's stake in IGXT legitimize our companies equity to other hedge funds and Wall Street in general?

Of course.

Congrats to all shares holders old and new. 2021 is going to be a life changing and rewarding year for the faithful and the timely.

My opinion only~
👍️0
The GidDy uP Kid The GidDy uP Kid 3 years ago
IGXT... .365... Daily psar fliPPed to the Bullish side... GidDy uP IGXT...
https://schrts.co/TrxquuPf

👍️0
GMA13 GMA13 3 years ago
Very simply put, initially Atai Life Sciences will own around 25% of the IGXT, and with exercising all Options, etc. around 60%.
• IGXT gets 12.6Mil cash plus a Secured Loan option.
• IGXT gets another robust specialty pipe-line, with the synergistic advantages of coming-development.

IMO - For a Company like IGXT, this is a fantastic deal both financially & for future pure play specialty growth. You will see the PPS soar once the Market analysts weigh-in.
👍️0
Reyeton Reyeton 3 years ago
Got these Analyist reports at seeking alpha. The titles of these reports and the dates they were written say it all:

HORST NEEDS TO STEP DOWN IMMEDIATLY. HE HAS CLEARLY DEMONSTRATED HE IS NOT CAPABLE OF BRINGING THIS COMPANY FORWARD, IMO.

The marketplace is screaming for our technology, IMO.

Analysis:

IntelGenx: A Small Cap With A Big Pipeline In Cannabis, Alzheimer's, And ED
Danny Upshaw Wed, Sep. 26, 2018

IntelGenx- Maintaining Buy Rating
Singular Research Thu, Nov. 12, 2015

This Small Cap Is Poised To Tap Multi-Billion Dollar Migraine Treatment Market
Tedra DeSue Thu, Oct. 16, 2014

Intelgenx Leadership Change And CRL Response: Why I'm Still Bullish
Alexander Maxwell Mon, Aug. 04, 2014

IntelGenx: A Compelling Investment Opportunity
Alexander Maxwell Fri, Jun. 27, 2014

The Ducks Are Lining Up For IntelGenx Bulls
Scientist on Stocks Mon, Jan. 27, 2014

IntelGenx Technologies: A Small Cap Company With The Potential For Significant Gains
Alexander Maxwell Sun, Jan. 26, 2014

IntelGenx CEO Provides Insight Into The Company's Catalysts
Ben Yoffe Tue, Feb. 05, 2013
👍️0
Reyeton Reyeton 3 years ago
Maybe a relationship with one of these companies:

https://thedalesreport.com/life-sciences/psychedelic-stocks-start-the-week-off-at-all-time-highs/
👍️0
Lc3ltd Lc3ltd 3 years ago
Expecting an announcement?
👍️0
RS500 RS500 3 years ago
Best SP since the last time you posted. Something will break, I expect to see at least $.50 by the end of the week.
👍️0
Lc3ltd Lc3ltd 3 years ago
https://finance.yahoo.com/news/intelgenx-enters-amended-restated-license-110000800.html
👍️0
SurgeGuy2.0 SurgeGuy2.0 4 years ago
Big day? Nope......this scam exposed a while back. Just not sure why folks cannot see how the corrupt CEO is bleeding this pig dry.
👍️0
IGXT_GLEN IGXT_GLEN 4 years ago
IMO, for them to issue this PR on the day after is both bold and confident... When has IGXT ever been forthcoming/timely with this caliber of news? NEVER! I think that once the meeting’s minutes have been received by IGXT from FDA there will be a “punch list” which will be difficult to misinterpret... Hopefully Horst remembers to sign it this time!!! LOL
👍️0
IGXT_GLEN IGXT_GLEN 4 years ago
Intelgenx received their Health Canada Microprocessing License today...
👍️0
SurgeGuy2.0 SurgeGuy2.0 4 years ago
Wow, egg on face? IGXT is GREEN again.....dang
👍️0
SurgeGuy2.0 SurgeGuy2.0 4 years ago
Mr. Cox owns you on this one......lolzzzzz
👍️0
SurgeGuy2.0 SurgeGuy2.0 4 years ago
Cox is in charge.....denial is futile....lolzzzzzzzz
👍️0
SurgeGuy2.0 SurgeGuy2.0 4 years ago
Still pumping this crap?
👍️0
bUrRpPPP! bUrRpPPP! 4 years ago
MASSIVE DILUTION NEWS OUT!

SAINT LAURENT, Quebec, May 28, 2020 -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQB:IGXT) (“IntelGenx” or the “Corporation”) today announced that it intends to issue shares of common stock (“Common Shares”) of the Corporation in payment of the outstanding $7,577,000 aggregate principal amount of the Corporation’s 8.00% convertible unsecured subordinated debentures due June 30, 2020 (the “Debentures”).

Under the terms of the trust indenture governing the Debentures (the “Indenture”), the Corporation has the option to satisfy its obligation to repay all or any portion of the principal amount of the Debentures outstanding by issuing and delivering Common Shares at a deemed price of 95% of the current market price (as defined in the Indenture) at the maturity date, subject to customary conditions set forth in the Indenture. The issuance of the Common Shares in repayment of the principal of the Debentures is subject to the acceptance by the TSX Venture Exchange (the “TSX-V”). The Common Shares issued in payment of interest on the Debentures will be issued pursuant to exemptions from the prospectus requirements of applicable securities laws.

The Corporation also announced today that a meeting of the holders of the Debentures (the “Meeting”) will be held on Thursday, June 25, 2020. Debentureholders as of the record date of May 28, 2020 will receive a notice and information circular in respect of the Meeting and information on how to attend the Meeting will be provided on the Corporation’s website in due course. As previously announced, the Corporation is proposing to amend the terms of the Debentures to extend the maturity date from June 30, 2020 to June 30, 2022 and reduce the conversion price from $1.35 to $0.50 (together, the “Proposed Amendments”). The Proposed Amendments, which have been conditionally approved by the TSX-V, remain subject to approval by the holders of not less than 66 2/3% of the outstanding principal amount of the Debentures represented at the Meeting. If debentureholder approval is obtained, the Corporation intends to proceed with the Proposed Amendments, including the extension of the maturity date, such that the intended repayment of principal in Common Shares on June 30, 2020 indicated above would no longer be required and would not occur.

The Debentures are listed on the TSX-V under the symbol “IGX.DB”.
👍️0
SurgeGuy2.0 SurgeGuy2.0 4 years ago
YIKES! SEC INVESTIGATIONS ARE NEVER GOOD!
👍️0
SurgeGuy2.0 SurgeGuy2.0 4 years ago
Why is the CEO pumping shares into the market? Employing second rate promoters is not going to help either.....
👍️0
IGXT_GLEN IGXT_GLEN 4 years ago
I’m willing to bet this has to do with the name change in the packaging issue with the commercialization partner. CBD strips alone within the next couple of weeks get this way higher... Rizaport resubmission will be a fast one and Fast tracked through the FDA. IMO
👍️0
Theboy56 Theboy56 4 years ago
So it's obvious to see management incompetence at least over the last 5 years. What is their end game, drain money from company live lavish life stile?? Do they have one of these pipeline options that could be successful maybe 10/20 percent chance?? Risk/Reward?? Thoughts???
👍️0
Tasso9 Tasso9 4 years ago
Ask yourself this before buying. How many shares will management pick up at this low price. I've met management and board members during the past 3 annual meetings. The second to last the CEO had no clue what I was doing showing up at the main plant. I explained I was there for the annual meeting. I sensed there something was not right. The first annual meeting i sensed the ceo to be arrogant. Lasf years annual meeting was stocked with employees, and maybe 5 investors. I drilled the ceo about timelines, and failures. The ceo seemed deceptive in his usually soft spoken pretentious voice. I guarantee you they will not pick up any shares at this low price. If they do it will be a token, maybe ten thousand dollars worth, so to continue this false hope. The ceo has been running a deceptive shell game with their pipeline, my opinion.
👍️0
SurgeGuy2.0 SurgeGuy2.0 4 years ago
Ouch, sorry to hear
👍️0
SurgeGuy2.0 SurgeGuy2.0 4 years ago
Extremely foolish to pmp this share selling Scam
👍️0
IGXT_GLEN IGXT_GLEN 4 years ago
I did 41k at $0.115ish Friday afternoon. Most longs did too... MPL in April get this back over .50+++
👍️0
SurgeGuy2.0 SurgeGuy2.0 4 years ago
Do you recommend folks buy down here?
👍️0
SurgeGuy2.0 SurgeGuy2.0 4 years ago
What moron of a CEO would try to pmp his company? Pathetic
👍️0
Theboy56 Theboy56 4 years ago
Unfortunately this is the history of IGXT say over the last 5 years or so have been following. Was fortunate to unload about 60 percent of my position over $1.20 when they had the couple day Tilray run up hype which only lasted a few days. It seems like company has so much potential(maybe more hype then real) but can never seem to deliver for shareholders!
👍️0
SurgeGuy2.0 SurgeGuy2.0 4 years ago
Big day tomorrow!

Yeah.....it sure was a big day.......just in the WRONG direction.......
👍️0
SurgeGuy2.0 SurgeGuy2.0 4 years ago
What is hilarious is that just a few days ago.....this was being pmped all over the place
👍️0
SurgeGuy2.0 SurgeGuy2.0 4 years ago
Holy Smokes.........Did this POS CRASH and BURN today or what?

This is classic Stinky Pinky P & D ............sorry
👍️0

Your Recent History

Delayed Upgrade Clock